Abstract
Viruses have been the cause of some of the world's worst and most dreadful diseases. COVID-19 is one of them, and it is the name given to the novel corona virus discovered in 2019. Due to the unavailability of any proven treatment, there is an urgent need for therapeutics for COVID-19. In this computational investigation, ADME profiles and bioactivity results of 2-deoxy D-glucose (1), Hydroxy chloroquine (2), and Favipiravir (3) compounds were calculated. Drug likeness criteria based on Lipinski and Veber’s rules indicate that the compounds have classic physicochemical and pharmacokinetic properties that make them a good candidate for oral drug administration.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call